Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)
Clinical trial NCT03143998 · WITHDRAWN
Trial details
- NCT number
- NCT03143998
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- WITHDRAWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2019-01-12
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.